What the Aducanumab Approval Reveals About Alzheimer Disease Research

Manly, J. J., & Glymour, M. M. (2021). What the Aducanumab Approval Reveals About Alzheimer Disease Research. JAMA Neurology, 78(11), 1305. https://doi.org/10.1001/jamaneurol.2021.3404
Authors:
Jennifer J Manly
M Maria Glymour
Affiliated Authors:
Jennifer J Manly
Columbia Affiliation:
Subjects:
Alzheimer Disease (MeSH)
Antibodies, Monoclonal, Humanized (MeSH)
Clinical Trials as Topic (MeSH)
Drug Approval (MeSH)
Ethnic and Racial Minorities (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1001/jamaneurol.2021.3404
PMID:
34605885
DOI:
10.1001/jamaneurol.2021.3404
Journal:
JAMA Neurology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: